PCVXVaxcyte, Inc.

$61.07

What is the market doing?

What the tape says about PCVX

Vaxcyte, Inc. is +103% over the past year while the S&P 500 is +23%: 81 points ahead of the market.

+103%

1-year return · S&P 500 +23%

vs 200-day average
+16%

vs 200-day average · a clear uptrend

RSI (14)
57

RSI (14) · neutral

Below its 52-week high
−3.5%

Below its 52-week high

2024-08-06$28.04 – $117.93 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$61.07
1 monthS&P 500 +3.7%
+9.7%
1 yearS&P 500 +23%
+103%
5 yearsS&P 500 +87%
+172%
vs 50-day average$54.67
+12%
52-week high
$63.29
52-week low
$29.67
Annualised volatility
66%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$455K
Calendar-year price return
YearReturn
2026 (year to date)+32%
2025−44%
2024+30%
2023+31%
2022+102%
2021−10%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan63 of 6+0.78%
Feb63 of 6+1.6%
Mar61 of 6−14%
Apr62 of 6−1.6%
May63 of 6+4.1%
Jun65 of 6+1.7%
Jul74 of 7+1.2%
Aug76 of 7+13%
Sep63 of 6+9.0%
Oct62 of 6+10%
Nov63 of 6−2.6%
Dec63 of 6+0.78%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.